|
Aug 6
|
Pfizer CEO says has spoken with Trump, in ‘productive’ talks with government
|
|
Aug 6
|
Company News for Aug 6, 2025
|
|
Aug 6
|
BMY Stock Trades Near 52-Week Low: Time to Buy or Sell?
|
|
Aug 6
|
Pfizer Second Quarter 2025 Earnings: Beats Expectations
|
|
Aug 6
|
1 Reason to Buy Pfizer (PFE) Stock
|
|
Aug 6
|
US Health Department Ending Federal mRNA Vaccine Development
|
|
Aug 6
|
Healthcare Stocks Have Been Beaten Up. The Case for Buying Now.
|
|
Aug 6
|
Cancer Antibody Drug Conjugates Market Research 2025-2031 | Pfizer, AstraZeneca, and Biotechs Like Miracogen Advance Cancer ADCs with Strategic Acquisitions and Innovative Pipelines
|
|
Aug 5
|
Nxera Launches Broad Proprietary Pipeline Targeting Obesity and Chronic Weight Management
|
|
Aug 5
|
Podcast: Indexes Fall Modestly as Trump Expects Chip, Pharma Tariffs Soon
|
|
Aug 5
|
Health Care Roundup: Market Talk
|
|
Aug 5
|
Stocks to Watch Recap: Palantir, Coinbase, Gartner, Pfizer
|
|
Aug 5
|
US biotech needs government support to match China’s gains, Pfizer CEO says
|
|
Aug 5
|
These Stocks Moved the Most Today: Palantir, Vertex, Hims & Hers, Coinbase, BP, and More
|
|
Aug 5
|
Pfizer CEO shares 3 pillars of company's cost-cutting efforts
|
|
Aug 5
|
Why Shares of Pfizer Soared Today
|
|
Aug 5
|
Pfizer Smashes Earnings Forecasts And Raises Outlook; Shares Jump
|
|
Aug 5
|
Sector Update: Health Care Stocks Mixed in Late Afternoon Trading
|
|
Aug 5
|
Pfizer CEO details talks with Trump administration on tariffs, Most Favored Nations pricing
|
|
Aug 5
|
Pfizer Stock Rises as Earnings Smash Expectations. But These Challenges Remain.
|